瑞士
我们是谁
一项针对转移性结直肠癌晚期患者的 Nivolumab-relatlimab 固定剂量联合疗法对比瑞戈非尼或 TAS-102 的研究
BMS-986253与Nivolumab或Nivolumab加Ipilimumab联合治疗晚期癌症的研究
肿瘤诊断精准免疫肿瘤学和体细胞靶向合理性（TAPISTRY）平台研究
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
对 IV 期结直肠癌患者进行 ATP128、VSV-GP128 和 BI 754091 评估的 1b 期研究
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
